| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/30/2011 | CN101375872B Novel medicament prescription for treating diabetes |
| 03/30/2011 | CN101357215B Medicine combination for treating viral hepatitis and quality control method thereof |
| 03/30/2011 | CN101352517B Chinese medicine for treating lumbocrural pain and preparation method thereof |
| 03/30/2011 | CN101332282B Traditional Chinese medicine composition for treating gynecologic diseases from kidney deficiency and genitals coldness, and its preparation method |
| 03/30/2011 | CN101322787B Specific medicinal liquor for treating rheumatoild disease |
| 03/30/2011 | CN101244191B Medicament for treating fire and water scald |
| 03/30/2011 | CN101181441B Medicament for curing gonad progeria as well as preparation technique thereof |
| 03/30/2011 | CN101181339B Detection method of aidi injection preparations |
| 03/30/2011 | CN101112448B Donkey-hide gelatin composition having immunity improving effect and method of making the same |
| 03/30/2011 | CN101085045B Traditional Chinese medicine preparation for treating stomatitis |
| 03/30/2011 | CN101077152B Pearl facial-nourishing bean product and its manufacturing method |
| 03/30/2011 | CN101041016B Medicine for curing pituitary adenoma and its preparation method |
| 03/30/2011 | CN101029302B Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 03/29/2011 | US7915042 Keratinocytes expressing exogenous angiogenic growth factors |
| 03/29/2011 | US7915009 Modulating NF-kappa B by administering antigens or polynucleotide encoding antigens, antibody; treating cancer, tumor, Alzheimer's disease or a spongiform encephalopathy; DNA vaccine in kits |
| 03/29/2011 | US7914822 Method of producing nutritional products from human milk tissue and compositions thereof |
| 03/29/2011 | US7914821 Pharmaceutical composition for prevention and/or treatment of bone loss |
| 03/29/2011 | US7914783 Liquefying a vitreous and/or inducing posterior vitreous detachment of an eye via microplasmin injection; treating vision defects |
| 03/29/2011 | US7914779 Preparing solid support comprised of human placental stem cells for use in tissue regeneration and wound healing |
| 03/29/2011 | US7914477 Apparatus for the continuous separation of biological fluids into components and method of using same |
| 03/29/2011 | CA2410968C Method of treating chronic ulcers |
| 03/29/2011 | CA2392653C Production of vaccines |
| 03/29/2011 | CA2331071C A colostrum food composition and method of using same |
| 03/29/2011 | CA2237890C In vitro chondrogenic induction of human mesenchymal stem cells |
| 03/29/2011 | CA2228128C Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine |
| 03/24/2011 | WO2011035093A1 Probiotic stabilization |
| 03/24/2011 | WO2011035062A2 Spray dried human plasma |
| 03/24/2011 | WO2011035030A2 Induction of neuronal differentiation in non-neuronal cells using a nucleic acid molecule |
| 03/24/2011 | WO2011035018A2 Suicide ready cells |
| 03/24/2011 | WO2011034916A2 Bone substitute compositions, methods of preparation and clinical applications |
| 03/24/2011 | WO2011034447A1 Active composition from deer antler and methods of use |
| 03/24/2011 | WO2011034223A1 Composition for preventing and treating bone diseases, containing medicinal herb extracts as active ingredient |
| 03/24/2011 | WO2011034166A1 Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance |
| 03/24/2011 | WO2011034073A1 Novel method for producing differentiated cells |
| 03/24/2011 | WO2011033717A1 Goya koji composition |
| 03/24/2011 | WO2011033310A1 Encapsulated intestinal flora extracted from feces for use in the treatment of gastrointestinal disorders |
| 03/24/2011 | WO2011033275A1 Bacterial spore having therapeutic agent adsorbed on its surface |
| 03/24/2011 | WO2011033260A1 Stem cell conditioned medium compositions |
| 03/24/2011 | WO2011033129A1 Modified gram-negative bacteria for use as vaccines |
| 03/24/2011 | WO2011033090A1 Antigen specific tolerogenic antigen presenting cells and related uses compositions, methods and systems |
| 03/24/2011 | WO2010128524A3 Combined measles-malaria vaccine |
| 03/24/2011 | WO2010052467A3 Canine oral cavity probiotics |
| 03/24/2011 | WO2008038148A3 Stem cells and methods of making and using stem cells |
| 03/24/2011 | US20110071499 Free-standing biodegradable patch |
| 03/24/2011 | US20110071498 Free-standing biodegradable patch |
| 03/24/2011 | US20110071082 Long lasting anti-angiogenic peptides |
| 03/24/2011 | US20110070651 Recombinant viral vector for gene transfer into lymphoid cells |
| 03/24/2011 | US20110070644 Monocyte-Derived Stem Cells (MDSC) and Methods of Use Thereof |
| 03/24/2011 | US20110070605 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 03/24/2011 | US20110070313 Methods of inducing cell differentiation with placental extracts |
| 03/24/2011 | US20110070312 Bone matrix compositions and methods |
| 03/24/2011 | US20110070307 Tissue regeneration |
| 03/24/2011 | US20110070282 Materials and Methods for Treating Skeletal System Damage and Promoting Skeletal System Repair and Regeneration |
| 03/24/2011 | US20110070281 Reparative cell delivery via hyaluronic acid vehicles |
| 03/24/2011 | US20110070280 Method for differentiating embryonic stem cells into cells expressing aqp-1 |
| 03/24/2011 | US20110070272 Materials and Methods for Modulating Metabolism |
| 03/24/2011 | US20110070271 Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| 03/24/2011 | US20110070262 Viral Vectors and Their Use in Therapeutic Methods |
| 03/24/2011 | US20110070250 Therapeutical Composition Containing Dentritic Cells and use Thereof |
| 03/24/2011 | US20110070241 Methods for modulating immune responses to aav gene therapy vectors |
| 03/24/2011 | US20110070210 Systems and method for homeostatic blood states |
| 03/24/2011 | US20110070209 Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs |
| 03/24/2011 | US20110070208 Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof |
| 03/24/2011 | US20110070207 Therapeutic composition for atopic dermatitis |
| 03/24/2011 | US20110070206 Methods of applying physical stimuli to cells |
| 03/24/2011 | US20110070205 Multipotent stem cells and uses thereof |
| 03/24/2011 | US20110070204 Medium for handling and storing biological tissues of the musculoskeletal system outside an organism |
| 03/24/2011 | US20110070203 Mesendoderm and mesoderm cell populations |
| 03/24/2011 | US20110070202 Targeted delivery to the brain of magnetically labeled stem cells |
| 03/24/2011 | US20110070200 Abrogating proinflammatory cytokine production during oncolytic reovirus therapy |
| 03/24/2011 | US20110070199 Adaptable modified virus vector to deliver ribosomal ribonucleic acid combined with messenger ribonucleic acid as a medical treatment device to manage diabetes mellitus and other protein deficient dieases |
| 03/24/2011 | US20110070198 Plant-based biocidal materials and systems |
| 03/24/2011 | US20110070191 T cell receptor fusions and conjugates and methods of use there of |
| 03/24/2011 | US20110070164 Post release modification of viral envelopes |
| 03/24/2011 | CA2774729A1 Antigen specific tolerogenic antigen presenting cells and related uses compositions, methods and systems |
| 03/24/2011 | CA2774193A1 Novel method for producing differentiated cells |
| 03/24/2011 | CA2774073A1 Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance |
| 03/24/2011 | CA2772534A1 Probiotic stabilization |
| 03/23/2011 | EP2298927A2 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 03/23/2011 | EP2298864A2 Mesenchymal stem cells and uses therefor |
| 03/23/2011 | EP2298863A2 Mesenchymal stem cells and uses therefor |
| 03/23/2011 | EP2298862A2 Mesenchymal stem cells and uses therefor |
| 03/23/2011 | EP2298861A2 Mesenchymal stem cells and uses therefor |
| 03/23/2011 | EP2298359A1 Nucleic acid capable of controlling degranulation of mast cell |
| 03/23/2011 | EP2298357A1 Compositions and methods for regulated protein expression in gut |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298328A1 Use of umbilical cord blood cells for the treatment of neurological disorders |
| 03/23/2011 | EP2297330A1 Fviii muteins for treatment of von willebrand disease |
| 03/23/2011 | EP2297306A1 Human facilitating cells |
| 03/23/2011 | EP2297304A1 Human bone-forming cells in the treatment of conditions and bone diseases associated with immunodeficiency or immunosuppression |
| 03/23/2011 | EP2297303A2 Cell membrane engineering |
| 03/23/2011 | EP2296679A1 Abrogating proinflammatory cytokine production during oncolytic reovirus therapy |
| 03/23/2011 | EP2296678A1 Modulating interstitial pressure and oncolytic viral delivery and distribution |
| 03/23/2011 | EP2296677A1 Pro biotic foodstuff and/or drinking water adjunct and use thereof |
| 03/23/2011 | EP2296676A2 Cellular extracts |
| 03/23/2011 | EP2296675A1 Echinoderm-derived extracts, methods of preparation and uses thereof |
| 03/23/2011 | EP2296674A2 Novel adult progenitor cell |
| 03/23/2011 | EP2296673A1 Colostrum-derived fraction for wound healing and skin care |
| 03/23/2011 | EP2296672A1 Conditioned medium of liver progenitor cells |
| 03/23/2011 | EP2296643A1 Nutritional composition for improving the mammalian immune system |